Journal Name: Drug Design Development and Delivery Journal
ISSN: 2631-3278
DOI: 10.31021
Editor-in-Chief: Dr. Eugene Mananga
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
The Drug Design, Development and Delivery Journal (DDDD) is an international, peer-reviewed, open access journal published by Boffin Access Limited, dedicated to advancing innovation in pharmaceutical sciences, medicinal chemistry, and drug delivery systems. The journal provides a trusted global platform for researchers, clinicians, pharmacologists, and industry professionals to share novel findings that drive the future of therapeutics.
By integrating molecular design, preclinical development, and advanced delivery technologies, DDDD seeks to accelerate the translation of research into safe, effective, and patient-centered therapies.
The Drug Design, Development and Delivery Journal publishes high-quality contributions including original research articles, reviews, short communications, perspectives, and technical notes. Areas of interest include, but are not limited to:
Rational drug design, molecular modeling, and computational chemistry
Novel drug targets and mechanisms of action
High-throughput screening and lead optimization
Pharmacokinetics, pharmacodynamics, and ADME studies
Nanotechnology, biomaterials, and controlled drug delivery systems
Formulation science, biopharmaceutics, and dosage form innovations
Targeted drug delivery, gene delivery, and immunotherapeutics
Drug resistance, repurposing, and personalized medicine approaches
Regulatory science, clinical trial design, and translational medicine
Emerging technologies in vaccine development and biologics
Comprehensive Scope – Covers the full drug development pipeline from concept to clinical application.
Rigorous Peer Review – Submissions undergo strict double-blind peer review by domain experts.
Rapid Publication – Accepted articles are published online quickly to ensure timely visibility.
Global Readership – Open access ensures worldwide dissemination to researchers, clinicians, and pharmaceutical industries.
Multidisciplinary Platform – Bridges chemistry, biology, pharmacology, biotechnology, and clinical sciences.
Author Rights – Authors retain copyright under Creative Commons licensing, maximizing use and citation.
Enhanced Formats – Articles published in PDF, HTML, and supplementary formats including datasets and graphical abstracts.
DDDD upholds the highest editorial standards by adhering to COPE and ICMJE guidelines. All submissions are evaluated on originality, scientific quality, and ethical compliance.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.